Your browser doesn't support javascript.
loading
Moving Beyond Conventional Clinical Trial End Points in Treatment-refractory Metastatic Colorectal Cancer: A Composite Quality-of-life and Symptom Control End Point.
Gong, Jun; Wu, Daniel; Chuang, Jeremy; Tuli, Richard; Simard, John; Hendifar, Andrew.
Affiliation
  • Gong J; Department of Medical Oncology, City of Hope National Medical Center, Duarte, California.
  • Wu D; Department of Internal Medicine, Harbor-UCLA Medical Center, Torrance, California.
  • Chuang J; Department of Internal Medicine, Harbor-UCLA Medical Center, Torrance, California.
  • Tuli R; Gastrointestinal and Neuroendocrine Malignancies, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California.
  • Simard J; Xbiotech, Austin, Texas.
  • Hendifar A; Gastrointestinal and Neuroendocrine Malignancies, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: andrew.hendifar@cshs.org.
Clin Ther ; 39(11): 2135-2145, 2017 Nov.
Article in En | MEDLINE | ID: mdl-29079389

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Colorectal Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans / Male Language: En Journal: Clin Ther Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Colorectal Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans / Male Language: En Journal: Clin Ther Year: 2017 Document type: Article